Search Within

Yanming Zhang

  1. "Myeloma"
Formats
  1. Meeting Abstract (21)
  2. Journal Article (12)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (34)
  2. Department of Medicine (34)
  3. Department of Pathology and Laboratory Medicine (34)
  4. Hematologic Malignancies, Division of (34)
  5. Myeloma (34)
  6. Hematologic Malignancies Research (32)

More Groups

People
  1. Kylee Maclachlan (26)
  2. Malin Hultcrantz (25)
  3. Alexander Lesokhin (23)
  4. Ahmet Dogan (21)
  5. Heather Landau (18)
  6. Neha Korde (18)

More People

Years
  1. 2024 (4)
  2. 2023 (9)
  3. 2022 (5)
  4. 2021 (4)
  5. 2020 (9)
  6. 2019 (3)
Publications
  1. Blood (17)
  2. Clinical Lymphoma, Myeloma and Leukemia (5)
  3. Nature Communications (3)
  4. Blood Cancer Journal (2)
  5. American Journal of Surgical Pathology (1)
  6. Blood Advances (1)

More Publications

Publishers
  1. American Society of Hematology (18)
  2. Elsevier Inc. (5)
  3. Nature Publishing Group (5)
  4. American Association for Cancer Research (2)
  5. American Society of Clinical Oncology (1)
  6. John Wiley & Sons (1)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic complexity correlates with the degree of marrow independence of malignant plasma cells in the context of extramedullary disease
    Meeting Abstract

    Maclachlan, K. H.; Garces, J. J.; Shekarkhand, T.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Tan, C. R.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Comprehensive genomic sequencing predicts sub-optimal response to bispecific antibodies (BsAb) and chimeric antigen receptor T cells (CAR-T) in multiple myeloma (MM)
    Meeting Abstract

    Maclachlan, K.; Shekarkhand, T.; Farzana, T.; Costa, B.; Firestone, R.; Jurgens, E.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Shah, U.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Para-medullary (PMD) and extra-medullary (EMD) myeloma demonstrate increased copy number aberration, mutational burden, structural variants and genomic complexity compared to marrow-based myeloma
    Meeting Abstract

    Maclachlan, K.; Garcés, J. J.; Shekarkhand, T.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Tan, C.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma
    Journal Article

    Cirrincione, A. M.; Poos, A. M.; Ziccheddu, B.; Kaddoura, M.; Bärtsch, M. A.; Maclachlan, K.; Chojnacka, M.; Diamond, B.; John, L.; Reichert, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Comprehensive genomic characterization of response and resistance to daratumumab-based quadruplet induction in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K. H.; Tan, C. R.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Nemirovsky, D.; Derkach, A.; McPherson, A.; Diamond, B.; Ziccheddu, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The complex structural variant chromothripsis can be defined on targeted sequencing panels, allowing direct clinical translation in order to improve multiple myeloma prognostication
    Meeting Abstract

    Maclachlan, K. H.; Ziccheddu, B.; Tan, C.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Diamond, B.; Hassoun, H.; Mailankody, S.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Revealing novel mechanisms underlying inactivation of tumor suppressor genes on duplicated chromosomes in multiple myeloma
    Meeting Abstract

    Cirrincione, A.; Kaddoura, M.; Poos, A. M.; Ziccheddu, B.; Maclachlan, K. H.; Chojnacka, M.; Diamond, B.; Blaney, P.; Gagler, D.; Zhang, Y.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical outcomes associated with del(17p) in newly diagnosed multiple myeloma treated with triplet and daratumumab-based quadruplet induction regimens
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
    Journal Article

    Maura, F.; Boyle, E. M.; Coffey, D.; Maclachlan, K.; Gagler, D.; Diamond, B.; Ghamlouch, H.; Blaney, P.; Ziccheddu, B.; Cirrincione, A.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Comprehensive genomic characterization of response and resistance to daratumumab based quadruplet induction in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K.; Tan, C. R.; Shekarkhand, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; McPherson, A.; Diamond, B.; Blaney, P.; Ziccheddu, B.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save